Ann Lee
Pediatrics · Houston, TXNPI 1881881746
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 58 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 21 manufacturers reported payments, led by Sanofi Pasteur Inc. at 24.2% of the total.
Across 58 payments — averaging $18.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi Pasteur Inc.$258
- Cranial Technologies, Inc$156
- Pfizer$109
- Sanofi-aventis U.S. LLC$84
- Phadia US Inc.$58
- Seqirus USA Inc$44
- plus $358 from 15 others
What the payments were for
- Food & beverage$1,065100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi Pasteur Inc. | 11 | $258 |
| Cranial Technologies, Inc | 11 | $156 |
| Pfizer | 6 | $109 |
| Sanofi-aventis U.S. LLC | 4 | $84 |
| Phadia US Inc. | 3 | $58 |
| Seqirus USA Inc | 2 | $44 |
| GSK | 3 | $43 |
| AstraZeneca | 2 | $43 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $39 |
| Genentech USA, Inc. | 2 | $31 |
| Alk-abello, Inc | 2 | $30 |
| Acadia Pharmaceuticals Inc | 1 | $25 |
| Ironshore Pharmaceuticals Inc. | 1 | $23 |
| Ultragenyx Pharmaceutical Inc. | 1 | $20 |
| LNHC, Inc | 1 | $19 |
| Collegium Pharmaceutical, Inc. | 1 | $17 |
| Shire North American Group Inc | 1 | $15 |
| Merck | 1 | $14 |
| Azurity Pharmaceuticals, Inc. | 1 | $14 |
| Adlon Therapeutics L.p. | 1 | $13 |
| Supernus Pharmaceuticals, Inc. | 1 | $12 |
How this compares
$1,065 in reported general payments places this provider in the 85th percentile of 5,361 pediatrics providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine | 11 | $277 |
Paid to pharmacies, not to this prescriber.
Other pediatrics in Houston
- Pedro PiedraHouston$729K
- Vernon SuttonHouston$90K
- Carlos BacinoHouston$53K
- Farida AbidHouston$50K
- Lindsay CameronHouston$32K
- Juan Torres SanchezHouston$31K
- Martin YudovichHouston$24K
- Raegan HuntHouston$23K
- Michael PickettHouston$14K
- Lara LeonhardtHouston$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.